- Home
- TARA vs OPRT Comparison
TARA vs OPRT Comparison
Compare TARA & OPRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TARA
- OPRT
- Stock Information
- Founded
- TARA N/A
- OPRT 2005
- Country
- TARA United States
- OPRT United States
- Employees
- TARA N/A
- OPRT N/A
- Industry
- TARA Biotechnology: Biological Products (No Diagnostic Substances)
- OPRT Finance: Consumer Services
- Sector
- TARA Health Care
- OPRT Finance
- Exchange
- TARA Nasdaq
- OPRT Nasdaq
- Market Cap
- TARA 158.2M
- OPRT 146.4M
- IPO Year
- TARA N/A
- OPRT 2019
- Fundamental
- Price
- TARA $3.72
- OPRT $7.89
- Analyst Decision
- TARA Strong Buy
- OPRT Buy
- Analyst Count
- TARA 3
- OPRT 4
- Target Price
- TARA $22.67
- OPRT $5.17
- AVG Volume (30 Days)
- TARA 270.4K
- OPRT 810.8K
- Earning Date
- TARA 03-12-2025
- OPRT 02-12-2025
- Dividend Yield
- TARA N/A
- OPRT N/A
- EPS Growth
- TARA N/A
- OPRT N/A
- EPS
- TARA N/A
- OPRT N/A
- Revenue
- TARA N/A
- OPRT $763,600,000.00
- Revenue This Year
- TARA N/A
- OPRT N/A
- Revenue Next Year
- TARA N/A
- OPRT $8.34
- P/E Ratio
- TARA N/A
- OPRT N/A
- Revenue Growth
- TARA N/A
- OPRT N/A
- 52 Week Low
- TARA $1.60
- OPRT $2.05
- 52 Week High
- TARA $10.48
- OPRT $9.25
- Technical
- Relative Strength Index (RSI)
- TARA 33.05
- OPRT 77.71
- Support Level
- TARA $3.91
- OPRT $5.43
- Resistance Level
- TARA $4.05
- OPRT $9.25
- Average True Range (ATR)
- TARA 0.29
- OPRT 0.71
- MACD
- TARA -0.07
- OPRT 0.27
- Stochastic Oscillator
- TARA 0.00
- OPRT 72.59
About TARA Protara Therapeutics Inc.
Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops, and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).
About OPRT Oportun Financial Corporation
Oportun Financial Corp is engaged in providing financial services to people who either do not have a credit score or who may have a limited credit history. The company offers Personal Loans, Auto Loans, unsecured personal loans, and secured personal loans, and provides deposit accounts, debit card services, and other transaction services to its customers. Its product offerings include small-dollar, unsecured installment loans and other products and services.